PRICES include / exclude VAT
>UNE standards>UNE CEN ISO/TS 20443:2018 - Health informatics - Identification of medicinal products - Implementation guidelines for ISO 11615 data elements and structures for the unique identification and exchange of regulated medicinal product information (ISO/TS 20443:2017) (Endorsed by Asociación Española de Normalización in July of 2018.)
in stockReleased: 2018-07-01
UNE CEN ISO/TS 20443:2018 - Health informatics - Identification of medicinal products - Implementation guidelines for ISO 11615 data elements and structures for the unique identification and exchange of regulated medicinal product information (ISO/TS 20443:2017) (Endorsed by Asociación Española de Normalización in July of 2018.)

UNE CEN ISO/TS 20443:2018

Health informatics - Identification of medicinal products - Implementation guidelines for ISO 11615 data elements and structures for the unique identification and exchange of regulated medicinal product information (ISO/TS 20443:2017) (Endorsed by Asociación Española de Normalización in July of 2018.)

Informática sanitaria. Identificación de medicamentos. Directrices de implementación para elementos de datos y estructuras ISO 11615 para la identificación única y el intercambio de información reglamentaria de los medicamentos (ISO/TS 20443:2017) (Ratificada por la Asociación Española de Normalización en julio de 2018.)

Format
Availability
Price and currency
English PDF
Immediate download
Printable
206.80 EUR
English Hardcopy
In stock
206.80 EUR
Standard number:UNE CEN ISO/TS 20443:2018
Pages:213
Released:2018-07-01
Status:Standard
DESCRIPTION

UNE CEN ISO/TS 20443:2018

This document defines concepts and describes data elements and their structural relationships, which are required for the unique identification and the detailed description of Medicinal Products. Taken together, all ISO IDMP standards (ISO 11615, ISO 11616, ISO 11238, ISO 11239 and ISO 11240) define, characterise, and uniquely identify regulated Medicinal Products for human use from approval, to post-marketing and renewal or withdrawal from the market, where applicable. Furthermore, to support successful information exchange in relation to the unique identification and characterisation of Medicinal Products, the normative use of HL7 common product model (CPM) and structured product labeling (SPL) messaging is described. References to the use of other relevant standards for Medicinal Product information are included in this document to support successful information exchange.